Xylo Technologies Ltd. Total Liabilities
Xylo Technologies Ltd. total liabilities. Based on the latest financial reports, Xylo Technologies Ltd. (XYLO) has total liabilities worth $19.96 Million USD as of December 2024. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check XYLO financial resilience to evaluate the company's liquid asset resilience ratio.
Total Liabilities of Xylo Technologies Ltd. (2016–2024)
Total liabilities of Xylo Technologies Ltd. from 2016 to 2024. This chart illustrates how Xylo Technologies Ltd.'s total liabilities have evolved over time, based on quarterly financial data. Explore long-term investment intensity of Xylo Technologies Ltd. to see how much of total assets are deployed in long-term investments.
Xylo Technologies Ltd. Competitors by Total Liabilities
The table below lists competitors of Xylo Technologies Ltd. ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Bloomsbury Publishing Plc
LSE:BMY
|
UK | GBX148.60 Million |
|
SARAMA RESOURCES LTD
F:48S1
|
Germany | €1.95 Million |
|
Aurora Spine Corp
V:ASG
|
Canada | CA$6.11 Million |
|
Foresight Group Holdings Limited
LSE:FSG
|
UK | GBX79.08 Million |
|
Saxlund Group AB
ST:SAXG
|
Sweden | Skr75.97 Million |
|
EXPLOITS DISCOVERY CORP.
F:634
|
Germany | €320.26K |
|
Aprea Therapeutics Inc
NASDAQ:APRE
|
USA | $3.82 Million |
|
Hwa Tai Industries Bhd
KLSE:8478
|
Malaysia | RM73.95 Million |
Liability Composition Analysis (2016–2024)
This chart breaks down Xylo Technologies Ltd.'s total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see XYLO asset base.
Liquidity & Leverage Metrics
Xylo Technologies Ltd. Total Liabilities Ratios Explained
Xylo Technologies Ltd. total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.14 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 1.11 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.53 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Xylo Technologies Ltd.'s debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Xylo Technologies Ltd. (2016–2024)
The table below shows the annual total liabilities of Xylo Technologies Ltd. from 2016 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | $19.96 Million | -36.56% |
| 2023-12-31 | $31.46 Million | -26.77% |
| 2022-12-31 | $42.96 Million | +417.80% |
| 2021-12-31 | $8.30 Million | +35.11% |
| 2020-12-31 | $6.14 Million | +18.03% |
| 2019-12-31 | $5.20 Million | +64.65% |
| 2018-12-31 | $3.16 Million | +85.99% |
| 2017-12-31 | $1.70 Million | -5.37% |
| 2016-12-31 | $1.80 Million | -- |
About Xylo Technologies Ltd.
Xylo Technologies Ltd, a technology-based company, provides medical-related devices and products in the United States, Europe, Great Britain, Israel, Canada, Asia, and internationally. It operates through Corporate, Online Advertising & Internet Traffic Routing, Online Event Management, and Real-estate and Electronics segments. The company offers Medigus Ultrasonic Surgical Endostapler, an endosc… Read more